Pz-cel 是一种研究性自体 COL7A1 基因校正表皮片疗法，由患者自己的皮肤细胞制成。这些细胞通过功能性 COL7A1 基因进行基因校正，在一次手术后即可扩展形成角质形成细胞片以覆盖伤口区域。该疗法被 FDA ...

Epidermolysis bullosa (EB) is the term given to a group ... There are three types of EB: simplex, junctional, and dystrophic. Each form has a specific cleavage plane within the epidermal-dermal ...

Tampere University has licensed a drug molecule intended for treating Epidermolysis Bullosa (EB), a group of rare and severe ...

All other foot nails were dystrophic (Figure 1 ... dermal-epidermal junction detachment, suggestive of epidermolysis bullosa (EB) (Figure 2). A study of the pedigree of his family revealed ...

Krystal Biotech KRYS reported fourth-quarter earnings per share of $1.52, which beat the Zacks Consensus Estimate of $1.29 as ...

South Side-based biotechnology firm Krystal Biotech Inc.'s stock is up 20% following its earnings call this morning.

Boca Raton, Florida Wednesday, February 12, 2025, 16:00 Hrs [IST] ...

Suggested remit: To appraise the clinical and cost effectiveness of Beremagene geperpavec within its marketing authorisation for treating skin wounds assocatied with dystrophic epidermolysis bullosa.

Scotiabank (TSX:BNS) increased its price target for INmune Bio Inc. (NASDAQ:INMB) shares to $23.00, up from the previous target of $22.00, while maintaining a Sector Outperform rating. The stock, ...